Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
3350.0000 -9.40 (-0.28%)
NSE Oct 16, 2026 13:31 PM
Volume: 21,087
 

logo
Ajanta Pharma Ltd.
04 Nov 2025
3350.00
-0.28%
ICICI Direct
Q2FY26- Momentum driven by US and India Business - Revenues grew ~14% YoY to 1354 crore driven by US and India branded business which grew ~48% / ~12% to 344 crore and 432 crore, respectively. Other branded businesses such as Asia and Africa witnessed the growth of 5% / 4% (on higher base) to 310 crore and 221 crore, respectively. On the operational front, EBITDA grew 5.4% YoY to ~328 crore (excluding forex losses of 41 crore, 9 % growth to ~369 crore) with margins at 24.2%...
Number of FII/FPI investors increased from 342 to 353 in Sep 2026 qtr.
More from Ajanta Pharma Ltd.
Recommended